-
公开(公告)号:US08067438B2
公开(公告)日:2011-11-29
申请号:US13078225
申请日:2011-04-01
申请人: Montse Llinas-Brunet , Murray Douglas Bailey , Punit R. Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida J. Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
发明人: Montse Llinas-Brunet , Murray Douglas Bailey , Punit R. Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida J. Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
IPC分类号: A61K31/04 , C07D215/38
CPC分类号: A61K31/4709 , A61K38/06 , A61K38/212 , C07K5/0808 , C07K5/0827 , Y02A50/463 , A61K2300/00
摘要: Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
-
公开(公告)号:US06642204B2
公开(公告)日:2003-11-04
申请号:US10353589
申请日:2003-01-29
IPC分类号: A61K3806
CPC分类号: C07K5/0808 , A61K38/00 , C07K5/0812 , C07K5/0827
摘要: Disclosed herein are compounds of formula (1): wherein R1 is hydroxy or NHSO2R1A wherein R1A is (C1-8)alkyl, (C3-7)cycloalkyl or {(C1-6)alkyl-(C3-7)cycloalkyl}, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O—(C1-6)alkyl, amido, amino or phenyl, or R1A is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O—(C1-6) alkyl, amido, amino or phenyl; R2 is (C4-6)cycloalkyl; R3 is t-butyl or (C5-6) cycloalkyl and R4 is (C4-6)cycloalkyl; or a pharmaceutically acceptable salt thereof. The compounds are useful as inhibitors of HCV NS3 protease.
摘要翻译: 本文公开的是式(1)的化合物:其中R 1是羟基或NHSO 2 R 1A,其中R 1A是(C 1-8)烷基,(C 3-7)环烷基或{(C 1-6)烷基 - (C 3-7)环烷基},它们都可以任选被卤素,氰基,硝基,O-(C 1-6)烷基,酰胺基,氨基或苯基取代1至3倍,或者R 1A是C 6或C 10芳基 氰基,硝基,(C 1-6)烷基,O-(C 1-6)烷基,酰胺基,氨基或苯基任选被1-3个取代; R 2是(C 4-6)环烷基; R 3是叔丁基或(C 5-6)环烷基,R 4是(C 4-6)环烷基; 或其药学上可接受的盐。 该化合物可用作HCV NS3蛋白酶的抑制剂。
-
公开(公告)号:US07119072B2
公开(公告)日:2006-10-10
申请号:US10353894
申请日:2003-01-29
IPC分类号: A61K38/00
CPC分类号: C07K5/0812 , A61K38/00 , C07K5/0806
摘要: Compounds of formula I: wherein R1 is hydroxy or NHSO2R1A wherein R1A is (C1-8)alkyl, (C3-7)cycloalkyl or {(C1-6)alkyl-(C3-7)cycloalkyl}, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O(C1-6)alkyl, amido, amino or phenyl, or R1A is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O(C1-6)alkyl, amido, amino or phenyl; R2 is (C5-6)cycloalkyl and R3 is cyclopentyl; or a pharmaceutically acceptable salt thereof, useful as inhibitors of the HCV NS3 protease.
摘要翻译: 式I化合物:其中R 1是羟基或NHSO 2 R 1A其中R 1A是(C 1 -C 6) (C 3-7)烷基,(C 3-7)环烷基或{(C 1-6 - )烷基 - (C 1-3 - 7)环烷基},它们都可以任选被卤素,氰基,硝基,O(C 1-6 - )烷基,酰氨基,氨基或苯基取代1至3倍,或R (C 1 -C 12)是C 6或C 10芳基,其任选被卤素,氰基,硝基取代1至3次, 1-6位烷基,O(C 1-6 - )烷基,酰氨基,氨基或苯基; R 2是(C 5-6)环烷基,R 3是环戊基; 或其药学上可接受的盐,其可用作HCV NS3蛋白酶的抑制剂。
-
-